Dexamethasone Patent Expiration

Dexamethasone is Used for treating eye conditions such as diabetic macular edema, macular edema, non-infectious uveitis, and uveitis by delivering an ocular implant. It was first introduced by Merck And Co Inc in its drug Decadron on Approved Prior to Jan 1, 1982. Other drugs containing Dexamethasone are Decaspray, Dextenza, Hexadrol, Hemady, Dexycu Kit, Decaderm, Ozurdex, Maxidex. 37 different companies have introduced drugs containing Dexamethasone.


Dexamethasone Patents

Given below is the list of patents protecting Dexamethasone, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Dextenza US12144889 Methods of treating allergic conjunctivitis Apr 26, 2041 Ocular Therapeutix
Dexycu Kit US11097061 Systems, kits and methods for loading and delivering a small volume dose from a syringe Jun 23, 2039 Eyepoint Pharms
Hemady US10537585 Compositions comprising dexamethasone Dec 18, 2037 Dexcel
Hemady US11304961 Compositions comprising dexamethasone Dec 18, 2037 Dexcel
Dextenza US11458041 Punctal plug and bioadhesives Nov 16, 2037 Ocular Therapeutix
Dextenza US12150896 Punctal plug and bioadhesives Oct 07, 2036 Ocular Therapeutix
Dexycu Kit US10022502 Dose guides for injection syringe Jun 22, 2034 Eyepoint Pharms
Dexycu Kit US10028965 Use of sustained release dexamethasone in post-cataract surgery inflammation May 23, 2034 Eyepoint Pharms
Dexycu Kit US10159683 Use of sustained release dexamethasone in post-cataract surgery inflammation May 23, 2034 Eyepoint Pharms
Dexycu Kit US10799642 Dose guides for injection syringe May 11, 2032 Eyepoint Pharms
Dextenza US8409606 Drug delivery through hydrogel plugs May 14, 2030 Ocular Therapeutix
Dextenza US8563027 Drug delivery through hydrogel plugs Feb 12, 2030 Ocular Therapeutix
Dextenza US9254267 Composite hydrogel drug delivery systems Sep 11, 2024

(Expired)

Ocular Therapeutix
Ozurdex US6899717 Methods and apparatus for delivery of ocular implants Nov 01, 2023

(Expired)

Abbvie
Dexycu Kit US6960346 Vehicles for delivery of biologically active substances Jul 03, 2023

(Expired)

Eyepoint Pharms
Ozurdex US10076526 Ocular implant made by a double extrusion process Jan 09, 2023

(Expired)

Abbvie
Ozurdex US10702539 Ocular implant made by a double extrusion process Jan 09, 2023

(Expired)

Abbvie
Ozurdex US8034366 Ocular implant made by a double extrusion process Jan 09, 2023

(Expired)

Abbvie
Ozurdex US8034370 Ocular implant made by a double extrusion process Jan 09, 2023

(Expired)

Abbvie
Ozurdex US8506987 Ocular implant made by a double extrusion process Jan 09, 2023

(Expired)

Abbvie
Ozurdex US9192511 Ocular implant made by a double extrusion process Jan 09, 2023

(Expired)

Abbvie
Dexycu Kit US7560120 Vehicles for delivery of biologically active substances Sep 05, 2022

(Expired)

Eyepoint Pharms
Ozurdex US7767223 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use Nov 28, 2021

(Expired)

Abbvie
Ozurdex US6726918 Methods for treating inflammation-mediated conditions of the eye Oct 20, 2020

(Expired)

Abbvie
Ozurdex US7033605 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor Oct 20, 2020

(Expired)

Abbvie
Ozurdex US8043628 Methods for reducing edema Oct 20, 2020

(Expired)

Abbvie
Ozurdex US8063031 Implants and methods for treating inflammation-mediated conditions of the eye Oct 20, 2020

(Expired)

Abbvie
Ozurdex US8088407 Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor Oct 20, 2020

(Expired)

Abbvie
Ozurdex US9012437 Implants and methods for treating inflammation-mediated conditions of the eye Oct 20, 2020

(Expired)

Abbvie
Ozurdex US9283178 Methods for treating edema in the eye and intraocular implants for use therefor Oct 20, 2020

(Expired)

Abbvie
Ozurdex US9592242 Methods for treating edema in the eye and intraocular implants for use therefor Oct 20, 2020

(Expired)

Abbvie
Ozurdex US9775849 Implants and methods for treating inflammation-mediated conditions of the eye Oct 20, 2020

(Expired)

Abbvie



Dexamethasone's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Dexamethasone Generic API Manufacturers

Several generic applications have been filed for Dexamethasone. The first generic version for Dexamethasone was by Watson Laboratories Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Corepharma Llc and was approved on Sep 17, 2024.

Given below is the list of companies who have filed for Dexamethasone generic, along with the locations of their manufacturing plants worldwide.


Dexamethasone News

GSK promotes new success with Blenrep combination following withdrawal, while analysts predict significant growth.

07 Mar, 2024

See More